US 7846450
Melanoma associated peptide analogues and vaccines against melanoma
granted A61KA61K38/00A61P
Quick answer
US patent 7846450 (Melanoma associated peptide analogues and vaccines against melanoma) held by UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Grant date
- Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P37/04